Global Asthma Medication Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Asthma Medication market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Asthma Medication Industry Forecast” looks at past sales and reviews total world Asthma Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Asthma Medication sales for 2025 through 2031. With Asthma Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Asthma Medication industry.
This Insight Report provides a comprehensive analysis of the global Asthma Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Asthma Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Asthma Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Asthma Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Asthma Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Asthma Medication market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Asthma Medication market?
What factors are driving Asthma Medication market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Asthma Medication market opportunities vary by end market size?
How does Asthma Medication break out by Type, by Application?
The global Asthma Medication market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Asthma Medication Industry Forecast” looks at past sales and reviews total world Asthma Medication sales in 2024, providing a comprehensive analysis by region and market sector of projected Asthma Medication sales for 2025 through 2031. With Asthma Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Asthma Medication industry.
This Insight Report provides a comprehensive analysis of the global Asthma Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Asthma Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Asthma Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Asthma Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Asthma Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Asthma Medication market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Quick-Relief Medications
- Long-Term Control Medications
- Asthma Medications During Pregnancy
- Children
- Adolescent
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Dulera
- QVAR
- Glaxosmithkline plc
- MAP Pharmaceuticals?Inc
- Merck & Co. Inc
- AstraZeneca plc
- Roche Holdings Ltd
- Genentech Inc
- Sepracor, Inc
- Schering-Plough Corp
- Sanofi-Aventis
- Theravance Inc
What is the 10-year outlook for the global Asthma Medication market?
What factors are driving Asthma Medication market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Asthma Medication market opportunities vary by end market size?
How does Asthma Medication break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Asthma Medication Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Asthma Medication by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Asthma Medication by Country/Region, 2020, 2024 & 2031
2.2 Asthma Medication Segment by Type
2.2.1 Quick-Relief Medications
2.2.2 Long-Term Control Medications
2.2.3 Asthma Medications During Pregnancy
2.3 Asthma Medication Sales by Type
2.3.1 Global Asthma Medication Sales Market Share by Type (2020-2025)
2.3.2 Global Asthma Medication Revenue and Market Share by Type (2020-2025)
2.3.3 Global Asthma Medication Sale Price by Type (2020-2025)
2.4 Asthma Medication Segment by Application
2.4.1 Children
2.4.2 Adolescent
2.4.3 Adult
2.5 Asthma Medication Sales by Application
2.5.1 Global Asthma Medication Sale Market Share by Application (2020-2025)
2.5.2 Global Asthma Medication Revenue and Market Share by Application (2020-2025)
2.5.3 Global Asthma Medication Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Asthma Medication Breakdown Data by Company
3.1.1 Global Asthma Medication Annual Sales by Company (2020-2025)
3.1.2 Global Asthma Medication Sales Market Share by Company (2020-2025)
3.2 Global Asthma Medication Annual Revenue by Company (2020-2025)
3.2.1 Global Asthma Medication Revenue by Company (2020-2025)
3.2.2 Global Asthma Medication Revenue Market Share by Company (2020-2025)
3.3 Global Asthma Medication Sale Price by Company
3.4 Key Manufacturers Asthma Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Asthma Medication Product Location Distribution
3.4.2 Players Asthma Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ASTHMA MEDICATION BY GEOGRAPHIC REGION
4.1 World Historic Asthma Medication Market Size by Geographic Region (2020-2025)
4.1.1 Global Asthma Medication Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Asthma Medication Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Asthma Medication Market Size by Country/Region (2020-2025)
4.2.1 Global Asthma Medication Annual Sales by Country/Region (2020-2025)
4.2.2 Global Asthma Medication Annual Revenue by Country/Region (2020-2025)
4.3 Americas Asthma Medication Sales Growth
4.4 APAC Asthma Medication Sales Growth
4.5 Europe Asthma Medication Sales Growth
4.6 Middle East & Africa Asthma Medication Sales Growth
5 AMERICAS
5.1 Americas Asthma Medication Sales by Country
5.1.1 Americas Asthma Medication Sales by Country (2020-2025)
5.1.2 Americas Asthma Medication Revenue by Country (2020-2025)
5.2 Americas Asthma Medication Sales by Type (2020-2025)
5.3 Americas Asthma Medication Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Asthma Medication Sales by Region
6.1.1 APAC Asthma Medication Sales by Region (2020-2025)
6.1.2 APAC Asthma Medication Revenue by Region (2020-2025)
6.2 APAC Asthma Medication Sales by Type (2020-2025)
6.3 APAC Asthma Medication Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Asthma Medication by Country
7.1.1 Europe Asthma Medication Sales by Country (2020-2025)
7.1.2 Europe Asthma Medication Revenue by Country (2020-2025)
7.2 Europe Asthma Medication Sales by Type (2020-2025)
7.3 Europe Asthma Medication Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Asthma Medication by Country
8.1.1 Middle East & Africa Asthma Medication Sales by Country (2020-2025)
8.1.2 Middle East & Africa Asthma Medication Revenue by Country (2020-2025)
8.2 Middle East & Africa Asthma Medication Sales by Type (2020-2025)
8.3 Middle East & Africa Asthma Medication Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Asthma Medication
10.3 Manufacturing Process Analysis of Asthma Medication
10.4 Industry Chain Structure of Asthma Medication
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Asthma Medication Distributors
11.3 Asthma Medication Customer
12 WORLD FORECAST REVIEW FOR ASTHMA MEDICATION BY GEOGRAPHIC REGION
12.1 Global Asthma Medication Market Size Forecast by Region
12.1.1 Global Asthma Medication Forecast by Region (2026-2031)
12.1.2 Global Asthma Medication Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Asthma Medication Forecast by Type (2026-2031)
12.7 Global Asthma Medication Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Dulera
13.1.1 Dulera Company Information
13.1.2 Dulera Asthma Medication Product Portfolios and Specifications
13.1.3 Dulera Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Dulera Main Business Overview
13.1.5 Dulera Latest Developments
13.2 QVAR
13.2.1 QVAR Company Information
13.2.2 QVAR Asthma Medication Product Portfolios and Specifications
13.2.3 QVAR Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 QVAR Main Business Overview
13.2.5 QVAR Latest Developments
13.3 Glaxosmithkline plc
13.3.1 Glaxosmithkline plc Company Information
13.3.2 Glaxosmithkline plc Asthma Medication Product Portfolios and Specifications
13.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Glaxosmithkline plc Main Business Overview
13.3.5 Glaxosmithkline plc Latest Developments
13.4 MAP Pharmaceuticals?Inc
13.4.1 MAP Pharmaceuticals?Inc Company Information
13.4.2 MAP Pharmaceuticals?Inc Asthma Medication Product Portfolios and Specifications
13.4.3 MAP Pharmaceuticals?Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 MAP Pharmaceuticals?Inc Main Business Overview
13.4.5 MAP Pharmaceuticals?Inc Latest Developments
13.5 Merck & Co. Inc
13.5.1 Merck & Co. Inc Company Information
13.5.2 Merck & Co. Inc Asthma Medication Product Portfolios and Specifications
13.5.3 Merck & Co. Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merck & Co. Inc Main Business Overview
13.5.5 Merck & Co. Inc Latest Developments
13.6 AstraZeneca plc
13.6.1 AstraZeneca plc Company Information
13.6.2 AstraZeneca plc Asthma Medication Product Portfolios and Specifications
13.6.3 AstraZeneca plc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 AstraZeneca plc Main Business Overview
13.6.5 AstraZeneca plc Latest Developments
13.7 Roche Holdings Ltd
13.7.1 Roche Holdings Ltd Company Information
13.7.2 Roche Holdings Ltd Asthma Medication Product Portfolios and Specifications
13.7.3 Roche Holdings Ltd Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Roche Holdings Ltd Main Business Overview
13.7.5 Roche Holdings Ltd Latest Developments
13.8 Genentech Inc
13.8.1 Genentech Inc Company Information
13.8.2 Genentech Inc Asthma Medication Product Portfolios and Specifications
13.8.3 Genentech Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Genentech Inc Main Business Overview
13.8.5 Genentech Inc Latest Developments
13.9 Sepracor, Inc
13.9.1 Sepracor, Inc Company Information
13.9.2 Sepracor, Inc Asthma Medication Product Portfolios and Specifications
13.9.3 Sepracor, Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sepracor, Inc Main Business Overview
13.9.5 Sepracor, Inc Latest Developments
13.10 Schering-Plough Corp
13.10.1 Schering-Plough Corp Company Information
13.10.2 Schering-Plough Corp Asthma Medication Product Portfolios and Specifications
13.10.3 Schering-Plough Corp Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Schering-Plough Corp Main Business Overview
13.10.5 Schering-Plough Corp Latest Developments
13.11 Sanofi-Aventis
13.11.1 Sanofi-Aventis Company Information
13.11.2 Sanofi-Aventis Asthma Medication Product Portfolios and Specifications
13.11.3 Sanofi-Aventis Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sanofi-Aventis Main Business Overview
13.11.5 Sanofi-Aventis Latest Developments
13.12 Theravance Inc
13.12.1 Theravance Inc Company Information
13.12.2 Theravance Inc Asthma Medication Product Portfolios and Specifications
13.12.3 Theravance Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Theravance Inc Main Business Overview
13.12.5 Theravance Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Asthma Medication Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Asthma Medication Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Quick-Relief Medications
Table 4. Major Players of Long-Term Control Medications
Table 5. Major Players of Asthma Medications During Pregnancy
Table 6. Global Asthma Medication Sales byType (2020-2025) & (K Units)
Table 7. Global Asthma Medication Sales Market Share byType (2020-2025)
Table 8. Global Asthma Medication Revenue byType (2020-2025) & ($ million)
Table 9. Global Asthma Medication Revenue Market Share byType (2020-2025)
Table 10. Global Asthma Medication Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Asthma Medication Sale by Application (2020-2025) & (K Units)
Table 12. Global Asthma Medication Sale Market Share by Application (2020-2025)
Table 13. Global Asthma Medication Revenue by Application (2020-2025) & ($ million)
Table 14. Global Asthma Medication Revenue Market Share by Application (2020-2025)
Table 15. Global Asthma Medication Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Asthma Medication Sales by Company (2020-2025) & (K Units)
Table 17. Global Asthma Medication Sales Market Share by Company (2020-2025)
Table 18. Global Asthma Medication Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Asthma Medication Revenue Market Share by Company (2020-2025)
Table 20. Global Asthma Medication Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Asthma Medication Producing Area Distribution and Sales Area
Table 22. Players Asthma Medication Products Offered
Table 23. Asthma Medication Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Asthma Medication Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Asthma Medication Sales Market Share Geographic Region (2020-2025)
Table 28. Global Asthma Medication Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Asthma Medication Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Asthma Medication Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Asthma Medication Sales Market Share by Country/Region (2020-2025)
Table 32. Global Asthma Medication Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Asthma Medication Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Asthma Medication Sales by Country (2020-2025) & (K Units)
Table 35. Americas Asthma Medication Sales Market Share by Country (2020-2025)
Table 36. Americas Asthma Medication Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Asthma Medication Sales byType (2020-2025) & (K Units)
Table 38. Americas Asthma Medication Sales by Application (2020-2025) & (K Units)
Table 39. APAC Asthma Medication Sales by Region (2020-2025) & (K Units)
Table 40. APAC Asthma Medication Sales Market Share by Region (2020-2025)
Table 41. APAC Asthma Medication Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Asthma Medication Sales byType (2020-2025) & (K Units)
Table 43. APAC Asthma Medication Sales by Application (2020-2025) & (K Units)
Table 44. Europe Asthma Medication Sales by Country (2020-2025) & (K Units)
Table 45. Europe Asthma Medication Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Asthma Medication Sales byType (2020-2025) & (K Units)
Table 47. Europe Asthma Medication Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Asthma Medication Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Asthma Medication Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Asthma Medication Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Asthma Medication Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Asthma Medication
Table 53. Key Market Challenges & Risks of Asthma Medication
Table 54. Key IndustryTrends of Asthma Medication
Table 55. Asthma Medication Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Asthma Medication Distributors List
Table 58. Asthma Medication Customer List
Table 59. Global Asthma Medication SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Asthma Medication RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Asthma Medication SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Asthma Medication Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Asthma Medication SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Asthma Medication Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Asthma Medication SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Asthma Medication RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Asthma Medication SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Asthma Medication RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Asthma Medication SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Asthma Medication RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Asthma Medication SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Asthma Medication RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Dulera Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 74. Dulera Asthma Medication Product Portfolios and Specifications
Table 75. Dulera Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Dulera Main Business
Table 77. Dulera Latest Developments
Table 78. QVAR Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 79. QVAR Asthma Medication Product Portfolios and Specifications
Table 80. QVAR Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. QVAR Main Business
Table 82. QVAR Latest Developments
Table 83. Glaxosmithkline plc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 84. Glaxosmithkline plc Asthma Medication Product Portfolios and Specifications
Table 85. Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Glaxosmithkline plc Main Business
Table 87. Glaxosmithkline plc Latest Developments
Table 88. MAP Pharmaceuticals?Inc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 89. MAP Pharmaceuticals?Inc Asthma Medication Product Portfolios and Specifications
Table 90. MAP Pharmaceuticals?Inc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. MAP Pharmaceuticals?Inc Main Business
Table 92. MAP Pharmaceuticals?Inc Latest Developments
Table 93. Merck & Co. Inc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck & Co. Inc Asthma Medication Product Portfolios and Specifications
Table 95. Merck & Co. Inc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Merck & Co. Inc Main Business
Table 97. Merck & Co. Inc Latest Developments
Table 98. AstraZeneca plc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca plc Asthma Medication Product Portfolios and Specifications
Table 100. AstraZeneca plc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. AstraZeneca plc Main Business
Table 102. AstraZeneca plc Latest Developments
Table 103. Roche Holdings Ltd Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Holdings Ltd Asthma Medication Product Portfolios and Specifications
Table 105. Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Roche Holdings Ltd Main Business
Table 107. Roche Holdings Ltd Latest Developments
Table 108. Genentech Inc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 109. Genentech Inc Asthma Medication Product Portfolios and Specifications
Table 110. Genentech Inc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Genentech Inc Main Business
Table 112. Genentech Inc Latest Developments
Table 113. Sepracor, Inc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 114. Sepracor, Inc Asthma Medication Product Portfolios and Specifications
Table 115. Sepracor, Inc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Sepracor, Inc Main Business
Table 117. Sepracor, Inc Latest Developments
Table 118. Schering-Plough Corp Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 119. Schering-Plough Corp Asthma Medication Product Portfolios and Specifications
Table 120. Schering-Plough Corp Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Schering-Plough Corp Main Business
Table 122. Schering-Plough Corp Latest Developments
Table 123. Sanofi-Aventis Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi-Aventis Asthma Medication Product Portfolios and Specifications
Table 125. Sanofi-Aventis Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Sanofi-Aventis Main Business
Table 127. Sanofi-Aventis Latest Developments
Table 128.Theravance Inc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 129.Theravance Inc Asthma Medication Product Portfolios and Specifications
Table 130.Theravance Inc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131.Theravance Inc Main Business
Table 132.Theravance Inc Latest Developments
LIST OFFIGURES
Figure 1. Picture of Asthma Medication
Figure 2. Asthma Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Asthma Medication Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Asthma Medication Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Asthma Medication Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Asthma Medication Sales Market Share by Country/Region (2024)
Figure 10. Asthma Medication Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Quick-Relief Medications
Figure 12. Product Picture of Long-Term Control Medications
Figure 13. Product Picture of Asthma Medications During Pregnancy
Figure 14. Global Asthma Medication Sales Market Share byType in 2025
Figure 15. Global Asthma Medication Revenue Market Share byType (2020-2025)
Figure 16. Asthma Medication Consumed in Children
Figure 17. Global Asthma Medication Market: Children (2020-2025) & (K Units)
Figure 18. Asthma Medication Consumed in Adolescent
Figure 19. Global Asthma Medication Market: Adolescent (2020-2025) & (K Units)
Figure 20. Asthma Medication Consumed in Adult
Figure 21. Global Asthma Medication Market: Adult (2020-2025) & (K Units)
Figure 22. Global Asthma Medication Sale Market Share by Application (2024)
Figure 23. Global Asthma Medication Revenue Market Share by Application in 2025
Figure 24. Asthma Medication Sales by Company in 2025 (K Units)
Figure 25. Global Asthma Medication Sales Market Share by Company in 2025
Figure 26. Asthma Medication Revenue by Company in 2025 ($ millions)
Figure 27. Global Asthma Medication Revenue Market Share by Company in 2025
Figure 28. Global Asthma Medication Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Asthma Medication Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Asthma Medication Sales 2020-2025 (K Units)
Figure 31. Americas Asthma Medication Revenue 2020-2025 ($ millions)
Figure 32. APAC Asthma Medication Sales 2020-2025 (K Units)
Figure 33. APAC Asthma Medication Revenue 2020-2025 ($ millions)
Figure 34. Europe Asthma Medication Sales 2020-2025 (K Units)
Figure 35. Europe Asthma Medication Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Asthma Medication Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Asthma Medication Revenue 2020-2025 ($ millions)
Figure 38. Americas Asthma Medication Sales Market Share by Country in 2025
Figure 39. Americas Asthma Medication Revenue Market Share by Country (2020-2025)
Figure 40. Americas Asthma Medication Sales Market Share byType (2020-2025)
Figure 41. Americas Asthma Medication Sales Market Share by Application (2020-2025)
Figure 42. United States Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Asthma Medication Sales Market Share by Region in 2025
Figure 47. APAC Asthma Medication Revenue Market Share by Region (2020-2025)
Figure 48. APAC Asthma Medication Sales Market Share byType (2020-2025)
Figure 49. APAC Asthma Medication Sales Market Share by Application (2020-2025)
Figure 50. China Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 54. India Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Asthma Medication Sales Market Share by Country in 2025
Figure 58. Europe Asthma Medication Revenue Market Share by Country (2020-2025)
Figure 59. Europe Asthma Medication Sales Market Share byType (2020-2025)
Figure 60. Europe Asthma Medication Sales Market Share by Application (2020-2025)
Figure 61. Germany Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 62.France Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Asthma Medication Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Asthma Medication Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Asthma Medication Sales Market Share by Application (2020-2025)
Figure 69. Egypt Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Asthma Medication in 2025
Figure 75. Manufacturing Process Analysis of Asthma Medication
Figure 76. Industry Chain Structure of Asthma Medication
Figure 77. Channels of Distribution
Figure 78. Global Asthma Medication Sales MarketForecast by Region (2026-2031)
Figure 79. Global Asthma Medication Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Asthma Medication Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Asthma Medication Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Asthma Medication Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Asthma Medication Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Asthma Medication Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Asthma Medication by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Asthma Medication by Country/Region, 2020, 2024 & 2031
2.2 Asthma Medication Segment by Type
2.2.1 Quick-Relief Medications
2.2.2 Long-Term Control Medications
2.2.3 Asthma Medications During Pregnancy
2.3 Asthma Medication Sales by Type
2.3.1 Global Asthma Medication Sales Market Share by Type (2020-2025)
2.3.2 Global Asthma Medication Revenue and Market Share by Type (2020-2025)
2.3.3 Global Asthma Medication Sale Price by Type (2020-2025)
2.4 Asthma Medication Segment by Application
2.4.1 Children
2.4.2 Adolescent
2.4.3 Adult
2.5 Asthma Medication Sales by Application
2.5.1 Global Asthma Medication Sale Market Share by Application (2020-2025)
2.5.2 Global Asthma Medication Revenue and Market Share by Application (2020-2025)
2.5.3 Global Asthma Medication Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Asthma Medication Breakdown Data by Company
3.1.1 Global Asthma Medication Annual Sales by Company (2020-2025)
3.1.2 Global Asthma Medication Sales Market Share by Company (2020-2025)
3.2 Global Asthma Medication Annual Revenue by Company (2020-2025)
3.2.1 Global Asthma Medication Revenue by Company (2020-2025)
3.2.2 Global Asthma Medication Revenue Market Share by Company (2020-2025)
3.3 Global Asthma Medication Sale Price by Company
3.4 Key Manufacturers Asthma Medication Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Asthma Medication Product Location Distribution
3.4.2 Players Asthma Medication Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ASTHMA MEDICATION BY GEOGRAPHIC REGION
4.1 World Historic Asthma Medication Market Size by Geographic Region (2020-2025)
4.1.1 Global Asthma Medication Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Asthma Medication Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Asthma Medication Market Size by Country/Region (2020-2025)
4.2.1 Global Asthma Medication Annual Sales by Country/Region (2020-2025)
4.2.2 Global Asthma Medication Annual Revenue by Country/Region (2020-2025)
4.3 Americas Asthma Medication Sales Growth
4.4 APAC Asthma Medication Sales Growth
4.5 Europe Asthma Medication Sales Growth
4.6 Middle East & Africa Asthma Medication Sales Growth
5 AMERICAS
5.1 Americas Asthma Medication Sales by Country
5.1.1 Americas Asthma Medication Sales by Country (2020-2025)
5.1.2 Americas Asthma Medication Revenue by Country (2020-2025)
5.2 Americas Asthma Medication Sales by Type (2020-2025)
5.3 Americas Asthma Medication Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Asthma Medication Sales by Region
6.1.1 APAC Asthma Medication Sales by Region (2020-2025)
6.1.2 APAC Asthma Medication Revenue by Region (2020-2025)
6.2 APAC Asthma Medication Sales by Type (2020-2025)
6.3 APAC Asthma Medication Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Asthma Medication by Country
7.1.1 Europe Asthma Medication Sales by Country (2020-2025)
7.1.2 Europe Asthma Medication Revenue by Country (2020-2025)
7.2 Europe Asthma Medication Sales by Type (2020-2025)
7.3 Europe Asthma Medication Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Asthma Medication by Country
8.1.1 Middle East & Africa Asthma Medication Sales by Country (2020-2025)
8.1.2 Middle East & Africa Asthma Medication Revenue by Country (2020-2025)
8.2 Middle East & Africa Asthma Medication Sales by Type (2020-2025)
8.3 Middle East & Africa Asthma Medication Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Asthma Medication
10.3 Manufacturing Process Analysis of Asthma Medication
10.4 Industry Chain Structure of Asthma Medication
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Asthma Medication Distributors
11.3 Asthma Medication Customer
12 WORLD FORECAST REVIEW FOR ASTHMA MEDICATION BY GEOGRAPHIC REGION
12.1 Global Asthma Medication Market Size Forecast by Region
12.1.1 Global Asthma Medication Forecast by Region (2026-2031)
12.1.2 Global Asthma Medication Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Asthma Medication Forecast by Type (2026-2031)
12.7 Global Asthma Medication Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Dulera
13.1.1 Dulera Company Information
13.1.2 Dulera Asthma Medication Product Portfolios and Specifications
13.1.3 Dulera Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Dulera Main Business Overview
13.1.5 Dulera Latest Developments
13.2 QVAR
13.2.1 QVAR Company Information
13.2.2 QVAR Asthma Medication Product Portfolios and Specifications
13.2.3 QVAR Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 QVAR Main Business Overview
13.2.5 QVAR Latest Developments
13.3 Glaxosmithkline plc
13.3.1 Glaxosmithkline plc Company Information
13.3.2 Glaxosmithkline plc Asthma Medication Product Portfolios and Specifications
13.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Glaxosmithkline plc Main Business Overview
13.3.5 Glaxosmithkline plc Latest Developments
13.4 MAP Pharmaceuticals?Inc
13.4.1 MAP Pharmaceuticals?Inc Company Information
13.4.2 MAP Pharmaceuticals?Inc Asthma Medication Product Portfolios and Specifications
13.4.3 MAP Pharmaceuticals?Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 MAP Pharmaceuticals?Inc Main Business Overview
13.4.5 MAP Pharmaceuticals?Inc Latest Developments
13.5 Merck & Co. Inc
13.5.1 Merck & Co. Inc Company Information
13.5.2 Merck & Co. Inc Asthma Medication Product Portfolios and Specifications
13.5.3 Merck & Co. Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Merck & Co. Inc Main Business Overview
13.5.5 Merck & Co. Inc Latest Developments
13.6 AstraZeneca plc
13.6.1 AstraZeneca plc Company Information
13.6.2 AstraZeneca plc Asthma Medication Product Portfolios and Specifications
13.6.3 AstraZeneca plc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 AstraZeneca plc Main Business Overview
13.6.5 AstraZeneca plc Latest Developments
13.7 Roche Holdings Ltd
13.7.1 Roche Holdings Ltd Company Information
13.7.2 Roche Holdings Ltd Asthma Medication Product Portfolios and Specifications
13.7.3 Roche Holdings Ltd Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Roche Holdings Ltd Main Business Overview
13.7.5 Roche Holdings Ltd Latest Developments
13.8 Genentech Inc
13.8.1 Genentech Inc Company Information
13.8.2 Genentech Inc Asthma Medication Product Portfolios and Specifications
13.8.3 Genentech Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Genentech Inc Main Business Overview
13.8.5 Genentech Inc Latest Developments
13.9 Sepracor, Inc
13.9.1 Sepracor, Inc Company Information
13.9.2 Sepracor, Inc Asthma Medication Product Portfolios and Specifications
13.9.3 Sepracor, Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Sepracor, Inc Main Business Overview
13.9.5 Sepracor, Inc Latest Developments
13.10 Schering-Plough Corp
13.10.1 Schering-Plough Corp Company Information
13.10.2 Schering-Plough Corp Asthma Medication Product Portfolios and Specifications
13.10.3 Schering-Plough Corp Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Schering-Plough Corp Main Business Overview
13.10.5 Schering-Plough Corp Latest Developments
13.11 Sanofi-Aventis
13.11.1 Sanofi-Aventis Company Information
13.11.2 Sanofi-Aventis Asthma Medication Product Portfolios and Specifications
13.11.3 Sanofi-Aventis Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sanofi-Aventis Main Business Overview
13.11.5 Sanofi-Aventis Latest Developments
13.12 Theravance Inc
13.12.1 Theravance Inc Company Information
13.12.2 Theravance Inc Asthma Medication Product Portfolios and Specifications
13.12.3 Theravance Inc Asthma Medication Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Theravance Inc Main Business Overview
13.12.5 Theravance Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Asthma Medication Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Asthma Medication Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Quick-Relief Medications
Table 4. Major Players of Long-Term Control Medications
Table 5. Major Players of Asthma Medications During Pregnancy
Table 6. Global Asthma Medication Sales byType (2020-2025) & (K Units)
Table 7. Global Asthma Medication Sales Market Share byType (2020-2025)
Table 8. Global Asthma Medication Revenue byType (2020-2025) & ($ million)
Table 9. Global Asthma Medication Revenue Market Share byType (2020-2025)
Table 10. Global Asthma Medication Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Asthma Medication Sale by Application (2020-2025) & (K Units)
Table 12. Global Asthma Medication Sale Market Share by Application (2020-2025)
Table 13. Global Asthma Medication Revenue by Application (2020-2025) & ($ million)
Table 14. Global Asthma Medication Revenue Market Share by Application (2020-2025)
Table 15. Global Asthma Medication Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Asthma Medication Sales by Company (2020-2025) & (K Units)
Table 17. Global Asthma Medication Sales Market Share by Company (2020-2025)
Table 18. Global Asthma Medication Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Asthma Medication Revenue Market Share by Company (2020-2025)
Table 20. Global Asthma Medication Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Asthma Medication Producing Area Distribution and Sales Area
Table 22. Players Asthma Medication Products Offered
Table 23. Asthma Medication Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Asthma Medication Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Asthma Medication Sales Market Share Geographic Region (2020-2025)
Table 28. Global Asthma Medication Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Asthma Medication Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Asthma Medication Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Asthma Medication Sales Market Share by Country/Region (2020-2025)
Table 32. Global Asthma Medication Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Asthma Medication Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Asthma Medication Sales by Country (2020-2025) & (K Units)
Table 35. Americas Asthma Medication Sales Market Share by Country (2020-2025)
Table 36. Americas Asthma Medication Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Asthma Medication Sales byType (2020-2025) & (K Units)
Table 38. Americas Asthma Medication Sales by Application (2020-2025) & (K Units)
Table 39. APAC Asthma Medication Sales by Region (2020-2025) & (K Units)
Table 40. APAC Asthma Medication Sales Market Share by Region (2020-2025)
Table 41. APAC Asthma Medication Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Asthma Medication Sales byType (2020-2025) & (K Units)
Table 43. APAC Asthma Medication Sales by Application (2020-2025) & (K Units)
Table 44. Europe Asthma Medication Sales by Country (2020-2025) & (K Units)
Table 45. Europe Asthma Medication Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Asthma Medication Sales byType (2020-2025) & (K Units)
Table 47. Europe Asthma Medication Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Asthma Medication Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Asthma Medication Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Asthma Medication Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Asthma Medication Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Asthma Medication
Table 53. Key Market Challenges & Risks of Asthma Medication
Table 54. Key IndustryTrends of Asthma Medication
Table 55. Asthma Medication Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Asthma Medication Distributors List
Table 58. Asthma Medication Customer List
Table 59. Global Asthma Medication SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Asthma Medication RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Asthma Medication SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Asthma Medication Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Asthma Medication SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Asthma Medication Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Asthma Medication SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Asthma Medication RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Asthma Medication SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Asthma Medication RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Asthma Medication SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Asthma Medication RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Asthma Medication SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Asthma Medication RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Dulera Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 74. Dulera Asthma Medication Product Portfolios and Specifications
Table 75. Dulera Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Dulera Main Business
Table 77. Dulera Latest Developments
Table 78. QVAR Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 79. QVAR Asthma Medication Product Portfolios and Specifications
Table 80. QVAR Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. QVAR Main Business
Table 82. QVAR Latest Developments
Table 83. Glaxosmithkline plc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 84. Glaxosmithkline plc Asthma Medication Product Portfolios and Specifications
Table 85. Glaxosmithkline plc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Glaxosmithkline plc Main Business
Table 87. Glaxosmithkline plc Latest Developments
Table 88. MAP Pharmaceuticals?Inc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 89. MAP Pharmaceuticals?Inc Asthma Medication Product Portfolios and Specifications
Table 90. MAP Pharmaceuticals?Inc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. MAP Pharmaceuticals?Inc Main Business
Table 92. MAP Pharmaceuticals?Inc Latest Developments
Table 93. Merck & Co. Inc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 94. Merck & Co. Inc Asthma Medication Product Portfolios and Specifications
Table 95. Merck & Co. Inc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Merck & Co. Inc Main Business
Table 97. Merck & Co. Inc Latest Developments
Table 98. AstraZeneca plc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca plc Asthma Medication Product Portfolios and Specifications
Table 100. AstraZeneca plc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. AstraZeneca plc Main Business
Table 102. AstraZeneca plc Latest Developments
Table 103. Roche Holdings Ltd Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Holdings Ltd Asthma Medication Product Portfolios and Specifications
Table 105. Roche Holdings Ltd Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Roche Holdings Ltd Main Business
Table 107. Roche Holdings Ltd Latest Developments
Table 108. Genentech Inc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 109. Genentech Inc Asthma Medication Product Portfolios and Specifications
Table 110. Genentech Inc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Genentech Inc Main Business
Table 112. Genentech Inc Latest Developments
Table 113. Sepracor, Inc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 114. Sepracor, Inc Asthma Medication Product Portfolios and Specifications
Table 115. Sepracor, Inc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Sepracor, Inc Main Business
Table 117. Sepracor, Inc Latest Developments
Table 118. Schering-Plough Corp Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 119. Schering-Plough Corp Asthma Medication Product Portfolios and Specifications
Table 120. Schering-Plough Corp Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Schering-Plough Corp Main Business
Table 122. Schering-Plough Corp Latest Developments
Table 123. Sanofi-Aventis Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi-Aventis Asthma Medication Product Portfolios and Specifications
Table 125. Sanofi-Aventis Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Sanofi-Aventis Main Business
Table 127. Sanofi-Aventis Latest Developments
Table 128.Theravance Inc Basic Information, Asthma Medication Manufacturing Base, Sales Area and Its Competitors
Table 129.Theravance Inc Asthma Medication Product Portfolios and Specifications
Table 130.Theravance Inc Asthma Medication Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131.Theravance Inc Main Business
Table 132.Theravance Inc Latest Developments
LIST OFFIGURES
Figure 1. Picture of Asthma Medication
Figure 2. Asthma Medication Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Asthma Medication Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Asthma Medication Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Asthma Medication Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Asthma Medication Sales Market Share by Country/Region (2024)
Figure 10. Asthma Medication Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Quick-Relief Medications
Figure 12. Product Picture of Long-Term Control Medications
Figure 13. Product Picture of Asthma Medications During Pregnancy
Figure 14. Global Asthma Medication Sales Market Share byType in 2025
Figure 15. Global Asthma Medication Revenue Market Share byType (2020-2025)
Figure 16. Asthma Medication Consumed in Children
Figure 17. Global Asthma Medication Market: Children (2020-2025) & (K Units)
Figure 18. Asthma Medication Consumed in Adolescent
Figure 19. Global Asthma Medication Market: Adolescent (2020-2025) & (K Units)
Figure 20. Asthma Medication Consumed in Adult
Figure 21. Global Asthma Medication Market: Adult (2020-2025) & (K Units)
Figure 22. Global Asthma Medication Sale Market Share by Application (2024)
Figure 23. Global Asthma Medication Revenue Market Share by Application in 2025
Figure 24. Asthma Medication Sales by Company in 2025 (K Units)
Figure 25. Global Asthma Medication Sales Market Share by Company in 2025
Figure 26. Asthma Medication Revenue by Company in 2025 ($ millions)
Figure 27. Global Asthma Medication Revenue Market Share by Company in 2025
Figure 28. Global Asthma Medication Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Asthma Medication Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Asthma Medication Sales 2020-2025 (K Units)
Figure 31. Americas Asthma Medication Revenue 2020-2025 ($ millions)
Figure 32. APAC Asthma Medication Sales 2020-2025 (K Units)
Figure 33. APAC Asthma Medication Revenue 2020-2025 ($ millions)
Figure 34. Europe Asthma Medication Sales 2020-2025 (K Units)
Figure 35. Europe Asthma Medication Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Asthma Medication Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Asthma Medication Revenue 2020-2025 ($ millions)
Figure 38. Americas Asthma Medication Sales Market Share by Country in 2025
Figure 39. Americas Asthma Medication Revenue Market Share by Country (2020-2025)
Figure 40. Americas Asthma Medication Sales Market Share byType (2020-2025)
Figure 41. Americas Asthma Medication Sales Market Share by Application (2020-2025)
Figure 42. United States Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Asthma Medication Sales Market Share by Region in 2025
Figure 47. APAC Asthma Medication Revenue Market Share by Region (2020-2025)
Figure 48. APAC Asthma Medication Sales Market Share byType (2020-2025)
Figure 49. APAC Asthma Medication Sales Market Share by Application (2020-2025)
Figure 50. China Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 54. India Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Asthma Medication Sales Market Share by Country in 2025
Figure 58. Europe Asthma Medication Revenue Market Share by Country (2020-2025)
Figure 59. Europe Asthma Medication Sales Market Share byType (2020-2025)
Figure 60. Europe Asthma Medication Sales Market Share by Application (2020-2025)
Figure 61. Germany Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 62.France Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Asthma Medication Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Asthma Medication Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Asthma Medication Sales Market Share by Application (2020-2025)
Figure 69. Egypt Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Asthma Medication Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Asthma Medication in 2025
Figure 75. Manufacturing Process Analysis of Asthma Medication
Figure 76. Industry Chain Structure of Asthma Medication
Figure 77. Channels of Distribution
Figure 78. Global Asthma Medication Sales MarketForecast by Region (2026-2031)
Figure 79. Global Asthma Medication Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Asthma Medication Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Asthma Medication Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Asthma Medication Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Asthma Medication Revenue Market ShareForecast by Application (2026-2031)
